2026 Claims Handling Tactics Analysis
MetLife
Challenging Technical Denials, Lapse Violations, and ERISA Traps
MetLife’s recent restructuring and the divestiture of various life blocks to Corebridge Financial have created significant administrative gaps in claim processing. In 2026, we are observing a rise in “Paper-Only” medical reviews where MetLife-contracted physicians override treating doctors without a physical exam—a tactic frequently used to trigger AD&D exclusions. While many claims are initially denied or investigated for fraud, that small percentage represents thousands of MetLife families left without their expected financial security. This forensic analysis breaks down the specific technical hurdles required to reverse a MetLife denial in the current regulatory environment.
How MetLife Denies Claims: 2026 Trends
1. Non-ERISA vs. ERISA: The Tactical Pivot
MetLife treats “Individual” (Non-ERISA) policies differently than “Group” (ERISA) policies. Knowing which one you own changes your entire recovery strategy.
- Individual Policies (Non-ERISA): These are governed by State Contract Law. You have the right to a jury trial, bad faith damages, and emotional distress claims. MetLife is more likely to settle these cases quickly to avoid a public jury verdict.
- Group Policies (ERISA): Governed by Federal Law. No jury, no punitive damages. MetLife uses the “Discretionary Clause” to argue their denial only needs to be “reasonable,” not necessarily correct. Recovery requires an exhaustive Administrative Appeal.
2. Recent Regulatory Actions: The “Lapse” Defense
In 2025 and 2026, State Insurance Commissioners have issued multi-million dollar penalties against carriers for “Silent Lapses.” MetLife is strictly obligated to follow notification protocols that many internal claim examiners ignore.
Regulatory Compliance Checklist:
A. The Secondary Addressee Obligation: Under statutes like CA INS §10113.72, MetLife is legally required to notify every policyholder of their right to designate at least one other person to receive notice of lapse or termination for non-payment. If MetLife cannot prove they offered this right annually, the lapse is void.
B. The 30-Day Prior Notice: MetLife cannot terminate coverage unless they mailed a “Pending Lapse” letter to both the policyholder and the designee at least 30 days before the end of the grace period.
C. The 60-Day Grace Period: Any policy termination occurring before the 61st day of non-payment is a violation of law. We frequently find MetLife systems “auto-terminating” policies on Day 31.
3. Accidental Death: The “Proximate Cause” Rebuttal
MetLife’s AD&D denials often hinge on the “Contribution to Death” clause. If an underlying health condition is mentioned in the autopsy, they deny the claim. Our forensic rebuttal uses the “But-For” test: But for the accident, would the insured have died at that moment? If the accident was the “Dominant Cause,” the medical condition is incidental, and the benefit is due.
4. Material vs. Non-Material Misrepresentations
During a contestability investigation, MetLife often attempts to void a policy by citing a medical omission on the original application. However, a misrepresentation only provides legal grounds for denial if it is Material to the Risk. MetLife may point to a minor, non-material misstatement—such as a forgotten routine specialist visit or a managed condition that wouldn’t have prevented the policy from being issued—to justify a denial. If the omission would not have caused the insurer to reject the application or charge a significantly higher premium at the time of issuance, it cannot be used as a reason to deny a death claim. We audit MetLife’s internal underwriting manuals to prove that the “misrepresentation” is legally irrelevant to the risk they accepted.
Recovery Roadmap: MetLife Denial Reversal
| Step 1: The Designee Audit | Demand proof that MetLife mailed the Annual Designation Right notice. |
| Step 2: The Timeline Audit | Verify the exact date of the “Pending Lapse” letter vs. the “Termination” date. |
| Step 3: Medical Rebuttal | Challenge internal peer reviews with an independent forensic medical opinion. |
30 Years of MetLife Dispute Resolution. We Know the Tactics.
← View 2026 Denial Tactics for All Top 10 Carriers
Related 2026 Forensic Audit:
Facing a Group Life or employer-sponsored denial? Many of the ERISA tactics used by MetLife are also found in our latest Prudential analysis.
Forensic Reference & Statutory Sources
Our 2026 carrier audits are cross-referenced with data and regulatory standards from the following authorities:
Regulatory & Legal:
National Association of Insurance Commissioners (NAIC) |
ERISA (U.S. Dept of Labor) |
U.S. Securities and Exchange Commission (SEC)
State Statutes:
New York Insurance Regulations |
California Insurance Code |
Texas Administrative Code (Insurance)
Actuarial & Industry Data:
Society of Actuaries (SOA) |
LIMRA Industry Research
Note: Statutory links are provided for reference to 2026 notification compliance and “Silent Lapse” mandates.